KF

Kelly Foster

Professional Summary



Professional Overview


Kelly Foster is an accomplished clinical pharmacology executive with over 15 years of experience in the biotechnology and pharmaceutical industries. As the Vice President of Clinical Pharmacology at Leap Therapeutics, she leads the development and optimization of drug candidates, driving strategic decisions that advance the company's therapeutic pipeline.

Experience Summary



Current Role


As the Vice President of Clinical Pharmacology at Leap Therapeutics, Kelly is responsible for overseeing all aspects of the company's clinical pharmacology program. She collaborates closely with cross-functional teams to design and execute rigorous clinical studies, ensuring the safety and efficacy of Leap's novel therapeutics. Under her leadership, the clinical pharmacology team has successfully supported the advancement of multiple drug candidates through critical milestones, contributing to the company's growing pipeline.

Career Progression


Prior to joining Leap Therapeutics, Kelly served as the Vice President of Translational Medicine at Viridian Therapeutics, where she led the biomarker and pharmacokinetic/pharmacodynamic (PK/PD) strategies for the company's portfolio. Before that, she held roles of increasing responsibility at Pinteon Therapeutics, including Vice President of Biology and Senior Director of Biology. Kelly's early career experience also includes positions as Director of Pharmacology and Toxicology, and Associate Director of Biology, at Cadent Therapeutics, as well as a Research Scientist role at Vertex Pharmaceuticals.

Academic Background


Kelly holds a Ph.D. in Pharmacology from the Massachusetts Institute of Technology (MIT), where her doctoral research focused on developing novel approaches for drug delivery and targeting. She completed her postdoctoral fellowship at MIT, further expanding her expertise in translational pharmacology.

Areas of Expertise


  • Clinical pharmacology and pharmacokinetics

  • Biomarker development and implementation

  • Translational research and early-stage drug development

  • Cross-functional team leadership and collaboration

  • Strategic planning and decision-making


Professional Impact


Throughout her career, Kelly has made significant contributions to the advancement of therapeutic candidates in the areas of oncology, neurology, and rare diseases. Her work has been recognized through numerous publications in peer-reviewed journals and presentations at industry conferences. Kelly's deep understanding of the clinical pharmacology discipline and her ability to drive innovative solutions have been instrumental in driving the progress of several promising drug programs.

Conclusion


With her extensive expertise in clinical pharmacology and her proven track record of success, Kelly Foster is poised to continue making valuable contributions to the biotechnology industry. As the Vice President of Clinical Pharmacology at Leap Therapeutics, she is committed to leveraging her skills and experience to help the company advance its pipeline and ultimately improve patient outcomes.